Memory Pharmaceuticals
Montvale
About Memory Pharmaceuticals
Memory Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery and development of drug candidates for the treatment of central nervous system conditions. It offers drugs for neurological diseases associated with aging, such as Alzheimer's disease, as well as psychiatric disorders, such as schizophrenia, cognitive impairment associated with schizophrenia (CIAS), and depression. The company was incorporated in 1997 and is based in Montvale, New Jersey. As of December 31, 2008, Memory Pharmaceuticals Corp. operates as a subsidiary of Hoffmann-La Roche Inc.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Total funding: $41.0M
- Funding stage: M&A
- Last round: Post-IPO Debt (Mar 2007)
- Ticker: nasdaq:MEMY
- Website: memorypharma.com
- Phone: +1 201-802-7100
Industries & Categories
Biotechnology, Neuroscience, Pharmaceutical
Canonical: https://fsome.com/organization/memory-pharmaceuticals-3728274 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.